ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)

Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy.

Daniel Hollyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.